Morning Overview on MSN
People on Ozempic-style drugs quietly started moving less, a Fitbit study found
Adults who started taking GLP-1 receptor agonist drugs such as semaglutide logged fewer daily steps and less time exercising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results